Data / Drug companies / Siegfried AG
Siegfried AG: 24 products in the FDA NDC directory, labeler code 17205
Siegfried AG (labeler code 17205) lists 24 products in the FDA National Drug Code Directory. By type: 22 bulk ingredients, 2 drugs for further processing. Its main marketing category is bulk ingredients. The newest product started marketing on April 18, 2024.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 17205
- Products in commercial distribution
- 24
- Packages
- 24
- Finished drugs by generic name
- 0
- Prescription products
- 0
- Over the counter products
- 0
- Controlled substance products
- Schedule III 2, Schedule V 1
- Started marketing in the last 12 months
- 0
- Earliest marketing start
- December 7, 1973
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Bulk ingredients | 21 | 87.5% |
| Drugs for further processing | 2 | 8.3% |
| Bulk ingredients for compounding | 1 | 4.2% |
Products by type
| Type | Products | Share |
|---|---|---|
| Bulk ingredients | 22 | 91.7% |
| Drugs for further processing | 2 | 8.3% |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Powder | 23 | 95.8% |
| Liquid | 1 | 4.2% |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Venlafaxine hcl | 17205-567 | Powder | Bulk ingredients | April 18, 2024 |
| Lotilaner | 17205-629 | Powder | Bulk ingredients | August 14, 2023 |
| Zanubrutinib | 17205-628 | Powder | Drugs for further processing | June 16, 2023 |
| Thalidomide | 17205-205 | Powder | Drugs for further processing | April 1, 2023 |
| Primidone | 17205-308 | Powder | Bulk ingredients | June 30, 2020 |
| Oclacitinib maleate | 17205-097 | Powder | Bulk ingredients | April 12, 2019 |
| Sarolaner | 17205-099 | Powder | Bulk ingredients | January 31, 2019 |
| Pimavanserin tartrate | 17205-098 | Powder | Bulk ingredients | April 29, 2016 |
| Nicotine polacrilex | 17205-483 | Powder | Bulk ingredients | December 12, 2012 |
| Lacosamide | 17205-107 | Powder | Bulk ingredients | April 20, 2010 |
| Naltrexone base | 17205-102 | Powder | Bulk ingredients | April 14, 2010 |
| Naloxone hydrochloride | 17205-101 | Powder | Bulk ingredients | March 1, 2010 |
| Buprenorphine base | 17205-100 | Powder | Bulk ingredients | January 27, 2010 |
| Naltrexone hydrochloride | 17205-108 | Powder | Bulk ingredients for compounding | January 1, 2010 |
| Naltrexone hydrochloride | 17205-103 | Powder | Bulk ingredients | January 1, 2010 |
| Fluoxetine hcl | 17205-612 | Powder | Bulk ingredients | July 2, 2008 |
| Buprenorphine hcl | 17205-482 | Powder | Bulk ingredients | November 12, 2007 |
| Nicotine bitartrate dihydrate | 17205-105 | Powder | Bulk ingredients | March 9, 2004 |
| Topiramate | 17205-096 | Powder | Bulk ingredients | December 24, 1996 |
| Proparacaine hydrochloride | 17205-340 | Powder | Bulk ingredients | June 21, 1996 |
| Nicotine | 17205-601 | Liquid | Bulk ingredients | November 18, 1988 |
| Oxiconazole nitrate | 17205-104 | Powder | Bulk ingredients | October 22, 1984 |
| Trimethobenzamide hcl | 17205-416 | Powder | Bulk ingredients | February 27, 1981 |
| Primidone | 17205-307 | Powder | Bulk ingredients | December 7, 1973 |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.